BSE filing, NSE: RJSHAH. Summary written from the filing by ALFA Finder's alert engine.
R J Shah & Company Ltd: key numbers
- Share price
- ₹470.00
- Market cap
- ₹13.16 Cr
- Revenue (annual)
- ₹0.27 Cr
- Net profit (annual)
- ₹2.41 Cr
- P/E (TTM)
- 5.5×Sector 34.0×
- Promoter holding
- 53.28%+0.01% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from R J Shah & Company Ltd
All →R J Shah & Company Other Announcement
RJ Shah & Company Ltd filed the Regulation 74(5) certificate from its Registrar, Satellite Corporate Services, confirming dematerialization of shares for the quarter ended September 30, 2026.
R J Shah & Company Annual General Meeting
RJ Shah & Co held its AGM on 22 Sep 2026 where all four resolutions passed. Shareholders approved audited financials, dividend, director re-appointment, and related-party transactions.
Rj Shah & Company Annual Report
R.J. Shah & Company has submitted its Annual Report for FY 2025-26, including the notice for the 68th Annual General Meeting scheduled for September 22, 2026.
Rj Shah & Company Annual General Meeting
R.J. Shah & Co. Ltd. scheduled its 68th Annual General Meeting on September 22, 2026. The meeting will consider the declaration of a 25% dividend.
RJ Shah & Company Q1 FY27 Results: Net Profit ₹0.2 Cr, Up 0.0% YoY
RJ Shah & Company Ltd reported net profit of ₹0.2 Cr (+0.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.2 Cr · +0.0% YoY
Rj Shah & Company Board Meeting Date
R.J. Shah & Co. Ltd. has scheduled a board meeting for July 24, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.